Skip to main content

What the FDA labels say about taking them together

Nirmatrelvir/ritonavir and zidovudine

Nirmatrelvir/ritonavir's FDA label of February 19, 2026 names zidovudine in its drug interactions section; the zidovudine labels PlainMeds reads (3) do not name nirmatrelvir/ritonavir.

Check it at the source: the nirmatrelvir/ritonavir FDA label on DailyMed (effective February 19, 2026, Pfizer Laboratories Div Pfizer Inc); the zidovudine FDA label on DailyMed (effective February 10, 2025, Aurobindo Pharma Limited).

What does the nirmatrelvir/ritonavir label say about zidovudine?

Nirmatrelvir/ritonavir label, drug interactions

Drug Class: Anti-HIV; Drugs within Class: efavirenz, maraviroc, nevirapine, zidovudine, bictegravir/ emtricitabine/ tenofovir; Effect on Concentration: ↑ efavirenz ↑ maraviroc ↑ nevirapine ↓ zidovudine ↑ bictegravir ↔ emtricitabine ↑ tenofovir; Clinical Comments: For further information, refer to the respective anti-HIV drugs prescribing information.

Source: FDA drug label (Paxlovid), Pfizer Laboratories Div Pfizer Inc, effective February 19, 2026 (SPL set 8a99d6d6-fd9e-45bb-b1bf-48c7f761232a), via openFDA; the full label on DailyMed

What does the zidovudine label say about nirmatrelvir/ritonavir?

Zidovudine's label (effective February 10, 2025) and its 2 other brand-application labels do not name nirmatrelvir/ritonavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Zidovudine), Aurobindo Pharma Limited, effective February 10, 2025 (SPL set 51abd2ce-6be1-412d-b806-5f24935ac5e3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Nirmatrelvir/ritonavir generic labelers
3Zidovudine generic labelers
Nirmatrelvir/ritonavirZidovudine
Labeled forCOVID-19HIV
Boxed warningYesYes
Pharmacy cost (NADAC)$49.24 per unit 300-100 mg dose pack$0.464 per tablet 300 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?